Array Biopharma, Inc. (ARRY) Reports Q1 EPS Loss of $0.06, Sales Beat Expectations
Go back to Array Biopharma, Inc. (ARRY) Reports Q1 EPS Loss of $0.06, Sales Beat Expectations| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 4.12 -0.12 (2.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.24 | 52 Week High | $7.27 | |||
| Open | $4.07 | 52 Week Low | $2.39 | |||
| Day High | $4.15 | P/E | N/A | |||
| Day Low | $4.07 | EPS | $-0.61 | |||
| Volume | 522,832 | |||||
